Vascular Pericyte-Derived Exosomes Inhibit Bone Resorption via Traf3

References

• Teichert M, Milde L, Holm A, et al. Pericyte-expressed Tie2 controls angiogenesis and vessel maturation. Nat Commun. 2017;8(1):16106. doi:10.1038/ncomms16106
   PubMedGoogle Scholar
• Armulik A, Genové G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell. 2011;21(2):193–215. doi:10.1016/j.devcel.2011.07.001
   PubMed Web of Science ®Google Scholar
• Chim SM, Tickner J, Chow ST, et al. Angiogenic factors in bone local environment. Cytokine Growth Factor Rev. 2013;24(3):297–310. doi:10.1016/j.cytogfr.2013.03.008
   PubMed Web of Science ®Google Scholar
• Ramasamy SK, Kusumbe AP, Wang L, Adams RH. Endothelial notch activity promotes angiogenesis and osteogenesis in bone. Nature. 2014;507(7492):376–380. doi:10.1038/nature13146
   PubMed Web of Science ®Google Scholar
• Negri S, Wang Y, Sono T, et al. Human perivascular stem cells prevent bone graft resorption in osteoporotic contexts by inhibiting osteoclast formation. Stem Cells Transl Med. 2020;9(12):1617–1630. doi:10.1002/sctm.20-0152
   PubMed Web of Science ®Google Scholar
• Davaine JM, Quillard T, Brion R, et al. Osteoprotegerin, pericytes and bone-like vascular calcification are associated with carotid plaque stability. PLoS One. 2014;9(9):e107642. doi:10.1371/journal.pone.0107642
   PubMed Web of Science ®Google Scholar
• Davaine JM, Quillard T, Chatelais M, et al. Bone like arterial calcification in femoral atherosclerotic lesions: prevalence and role of osteoprotegerin and pericytes. Eur J Vasc Endovasc Surg. 2016;51(2):259–267. doi:10.1016/j.ejvs.2015.10.004
   PubMed Web of Science ®Google Scholar
• Elsharkasy OM, Nordin JZ, Hagey DW, et al. Extracellular vesicles as drug delivery systems: why and how? Adv Drug Deliv Rev. 2020;159:332–343. doi:10.1016/j.addr.2020.04.004
   PubMed Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478). doi:10.1126/science.aau6977
   PubMed Web of Science ®Google Scholar
• Huang M, Chen M, Qi M, et al. Perivascular cell-derived extracellular vesicles stimulate colorectal cancer revascularization after withdrawal of antiangiogenic drugs. J Extracell Vesicles. 2021;10(7):e12096. doi:10.1002/jev2.12096
   PubMed Web of Science ®Google Scholar
• Liu C, Ge HM, Liu BH, et al. Targeting pericyte-endothelial cell crosstalk by circular RNA-cPWWP2A inhibition aggravates diabetes-induced microvascular dysfunction. Proc Natl Acad Sci U S A. 2019;116(15):7455–7464. doi:10.1073/pnas.1814874116
   PubMed Web of Science ®Google Scholar
• Song H, Li X, Zhao Z, et al. Reversal of osteoporotic activity by endothelial cell-secreted bone targeting and biocompatible exosomes. Nano Lett. 2019;19(5):3040–3048. doi:10.1021/acs.nanolett.9b00287
   PubMed Web of Science ®Google Scholar
• Cooke VG, LeBleu VS, Keskin D, et al. Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. Cancer Cell. 2012;21(1):66–81. doi:10.1016/j.ccr.2011.11.024
   PubMed Web of Science ®Google Scholar
• Wilson CL, Stephenson SE, Higuero JP, Feghali-Bostwick C, Hung CF, Schnapp LM. Characterization of human PDGFR-β-positive pericytes from IPF and non-IPF lungs. Am J Physiol-Lung Cel Molecul Physiol. 2018;315(6):L991–L1002. doi:10.1152/ajplung.00289.2018
   PubMed Web of Science ®Google Scholar
• Li D, Liu J, Guo B, et al. Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation. Nat Commun. 2016;7(1):10872. doi:10.1038/ncomms10872
   PubMed Web of Science ®Google Scholar
• Smith ZJ, Lee C, Rojalin T, et al. Single exosome study reveals subpopulations distributed among cell lines with variability related to membrane content. J Extracell Vesicles. 2015;4(1):28533. doi:10.3402/jev.v4.28533
   PubMed Web of Science ®Google Scholar
• Zeng XZ, He LG, Wang S, et al. Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression. Acta Pharmacol Sin. 2016;37(2):255–263. doi:10.1038/aps.2015.85
   PubMed Web of Science ®Google Scholar
• Ozerdem U, Monosov E, Stallcup WB. NG2 proteoglycan expression by pericytes in pathological microvasculature. Microvascu Res. 2002;63(1):129–134. doi:10.1006/mvre.2001.2376
   PubMed Web of Science ®Google Scholar
• Murfee WL, Skalak TC, Peirce SM. Differential arterial/venous expression of NG2 proteoglycan in perivascular cells along microvessels: identifying a venule-specific phenotype. Microcircul. 2005;12(2):151–160. doi:10.1080/10739680590904955
   PubMed Web of Science ®Google Scholar
• Liu C, Shao ZM, Zhang L, et al. Human endomucin is an endothelial marker. Biochem Biophys Res Commun. 2001;288(1):129–136. doi:10.1006/bbrc.2001.5737
   PubMed Web of Science ®Google Scholar
• He JQ, Saha SK, Kang JR, Zarnegar B, Cheng G. Specificity of TRAF3 in its negative regulation of the noncanonical NF-kappa B pathway. J Biol Chem. 2007;282(6):3688–3694. doi:10.1074/jbc.M610271200
   PubMed Web of Science ®Google Scholar
• He JQ, Zarnegar B, Oganesyan G, et al. Rescue of TRAF3-null mice by p100 NF-κB deficiency. J Exp Med. 2006;203(11):2413–2418. doi:10.1084/jem.20061166
   PubMed Web of Science ®Google Scholar
• Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res. 2005;97(6):512–523. doi:10.1161/01.RES.0000182903.16652.d7
   PubMed Web of Science ®Google Scholar
• Shepro D, Morel NM. Pericyte physiology. FASEB j. 1993;7(11):1031–1038. doi:10.1096/fasebj.7.11.8370472
   PubMed Web of Science ®Google Scholar
• Cackowski FC, Anderson JL, Patrene KD, et al. Osteoclasts are important for bone angiogenesis. Blood. 2010;115(1):140–149. doi:10.1182/blood-2009-08-237628
   PubMed Web of Science ®Google Scholar
• Xie H, Cui Z, Wang L, et al. PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat Med. 2014;20(11):1270–1278. doi:10.1038/nm.3668
   PubMed Web of Science ®Google Scholar
• Xu R, Yallowitz A, Qin A, et al. Targeting skeletal endothelium to ameliorate bone loss. Nat Med. 2018;24(6):823–833. doi:10.1038/s41591-018-0020-z
   PubMed Web of Science ®Google Scholar
• Kenswil KJG, Jaramillo AC, Ping Z, et al. Characterization of endothelial cells associated with hematopoietic niche formation in humans identifies il-33 as an anabolic factor. Cell Rep. 2018;22(3):666–678. doi:10.1016/j.celrep.2017.12.070
   PubMed Web of Science ®Google Scholar
• Zaidi M, Alam AS, Bax BE, et al. Role of the endothelial cell in osteoclast control: new perspectives. Bone. 1993;14(2):97–102. doi:10.1016/8756-3282(93)90234-2
   PubMed Web of Science ®Google Scholar
• Yuan X, Wu Q, Wang P, et al. Exosomes derived from pericytes improve microcirculation and protect blood-spinal cord barrier after spinal cord injury in mice. Front Neurosci. 2019;13:319. doi:10.3389/fnins.2019.00319
   PubMed Web of Science ®Google Scholar
• Ye L, Guo H, Wang Y, et al. Exosomal circEhmt1 released from hypoxia-pretreated pericytes regulates high glucose-induced microvascular dysfunction via the nfia/nlrp3 pathway. Oxid Med Cell Longev. 2021;2021:8833098. doi:10.1155/2021/8833098
   PubMed Web of Science ®Google Scholar
• Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423(6937):337–342. doi:10.1038/nature01658
   PubMed Web of Science ®Google Scholar
• Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93(2):165–176. doi:10.1016/S0092-8674(00)81569-X
   PubMed Web of Science ®Google Scholar
• Suzuki N, Yoshimura Y, Deyama Y, Suzuki K, Kitagawa Y. Mechanical stress directly suppresses osteoclast differentiation in RAW264.7 cells. Int J Mol Med. 2008;21(3):291–296.
   PubMed Web of Science ®Google Scholar
• Boyce BF, Li J, Xing L, Yao Z. Bone remodeling and the role of traf3 in osteoclastic bone resorption. Front Immunol. 2018;9:2263. doi:10.3389/fimmu.2018.02263
   PubMed Web of Science ®Google Scholar
• Xiu Y, Xu H, Zhao C, et al. Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation. J Clin Invest. 2014;124(1):297–310. doi:10.1172/JCI66947
   PubMed Web of Science ®Google Scholar
• Xue Y, Liang Z, Fu X, Wang T, Xie Q, Ke D. IL-17A modulates osteoclast precursors’ apoptosis through autophagy-TRAF3 signaling during osteoclastogenesis. Biochem Biophys Res Commun. 2019;508(4):1088–1092. doi:10.1016/j.bbrc.2018.12.029
   PubMed Web of Science ®Google Scholar
• Xu S, Li S, Liu X, et al. Rictor is a novel regulator of TRAF6/TRAF3 in osteoclasts. J Bone Miner Res. 2021;36(10):2053–2064. doi:10.1002/jbmr.4398
   PubMed Web of Science ®Google Scholar
• Ke D, Zhu Y, Zheng W, Fu X, Chen J, Han J. Autophagy mediated by JNK1 resists apoptosis through TRAF3 degradation in osteoclastogenesis. Biochimie. 2019;167:217–227. doi:10.1016/j.biochi.2019.10.008
   PubMed Web of Science ®Google Scholar
• Li J, Ayoub A, Xiu Y, et al. TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis. Nat Commun. 2019;10(1):2795. doi:10.1038/s41467-019-10677-0
   PubMedGoogle Scholar
• Mulcahy LA, Pink RC, Carter DR. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014;3(1):24641.
   PubMedGoogle Scholar
• Pegtel DM, Gould SJ. Exosomes. Annu Rev Biochem. 2019;88(1):487–514. doi:10.1146/annurev-biochem-013118-111902
   PubMed Web of Science ®Google Scholar
• Taverna S, Pucci M, Giallombardo M, et al. Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway. Sci Rep. 2017;7(1):3170. doi:10.1038/s41598-017-03460-y
   PubMedGoogle Scholar
• Zhang Y, Xie RL, Croce CM, et al. A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proc Natl Acad Sci U S A. 2011;108(24):9863–9868. doi:10.1073/pnas.1018493108
   PubMed Web of Science ®Google Scholar
• Yang Z, Liu X, Zhao F, et al. Bioactive glass nanoparticles inhibit osteoclast differentiation and osteoporotic bone loss by activating lncRNA NRON expression in the extracellular vesicles derived from bone marrow mesenchymal stem cells. Biomaterials. 2022;283:121438. doi:10.1016/j.biomaterials.2022.121438
   PubMed Web of Science ®Google Scholar
• Zhu S, Bennett S, Kuek V, et al. Endothelial cells produce angiocrine factors to regulate bone and cartilage via versatile mechanisms. Theranostics. 2020;10(13):5957–5965. doi:10.7150/thno.45422
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang L, Cui J, et al. Maintaining hypoxia environment of subchondral bone alleviates osteoarthritis progression. Sci Adv. 2023;9(14):eabo7868. doi:10.1126/sciadv.abo7868
   PubMed Web of Science ®Google Scholar
• Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet. 2011;377(9773):1276–1287. doi:10.1016/S0140-6736(10)62349-5
   PubMed Web of Science ®Google Scholar
• Hu Y, Chen X, Wang S, Jing Y, Su J. Subchondral bone microenvironment in osteoarthritis and pain. Bone Res. 2021;9(1):20. doi:10.1038/s41413-021-00147-z
   PubMed Web of Science ®Google Scholar